MedTrace Logo

Statin Treatment for UnruptureD Intracranial anEurysms Study

NCT04149483 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-05-01

No results posted yet for this study

Summary

This study was designed to identify whether there is a measurable reduction in inflammation in walls of intracranial aneurysms with oral atorvastatin.

Conditions

  • Intracranial Aneurysm
  • Inflammation Vascular

Interventions

DRUG

Atorvastatin

One with the intervention (atorvastatin, 20mg OD), 30 patients for this arm.

DRUG

Placebos

One with the intervention (Placebo, 20mg OD), 30 patients for this arm.

Sponsors & Collaborators

  • Beijing Neurosurgical Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-07
Primary Completion
2021-02-01
Completion
2021-02-01

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04149483 on ClinicalTrials.gov